These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27532279)

  • 1. VA Extends New Hepatitis C Drugs to All Veterans in Its Health System.
    Graham J
    JAMA; 2016 Sep; 316(9):913-5. PubMed ID: 27532279
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success.
    Belperio PS; Chartier M; Gonzalez RI; Park AM; Ross DB; Morgan TR; Backus LI
    Infect Dis Clin North Am; 2018 Jun; 32(2):281-292. PubMed ID: 29778256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curing Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs.
    Belperio PS; Chartier M; Ross DB; Alaigh P; Shulkin D
    Ann Intern Med; 2017 Oct; 167(7):499-504. PubMed ID: 28973196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Treatment Uptake and Provider Specialty for Hepatitis C Virus (HCV) Infection in the Veterans Affairs Healthcare System: Results From the Electronically Retrieved Cohort of HCV-Infected Veterans (ERCHIVES).
    Butt AA; Yan P; Lo Re Iii V; Shaikh OS; Ross DB
    Clin Infect Dis; 2019 Feb; 68(5):857-859. PubMed ID: 30137251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing access for veterans with hepatitis C by enhancing use of clinical pharmacy specialists.
    Ourth HL; Groppi JA; Morreale AP; Jorgenson T; Himsel AS; Jacob DA
    J Am Pharm Assoc (2003); 2019; 59(3):398-402. PubMed ID: 30853345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence with hepatitis C therapy in the Department of Veterans Affairs.
    Iqbal SU; Cunningham F; Lee A; Miller DR; Li NC; Cheung R; Kazis L
    J Clin Pharm Ther; 2008 Jun; 33(3):251-61. PubMed ID: 18452412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between implementation strategy use and the uptake of hepatitis C treatment in a national sample.
    Rogal SS; Yakovchenko V; Waltz TJ; Powell BJ; Kirchner JE; Proctor EK; Gonzalez R; Park A; Ross D; Morgan TR; Chartier M; Chinman MJ
    Implement Sci; 2017 May; 12(1):60. PubMed ID: 28494811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating Hepatitis C in Individuals With Previous Incarceration: The Veterans Health Administration, 2012-2019.
    Hawks L; Wang EA; Butt AA; Crystal S; Keith McInnes D; Re VL; Cartwright EJ; Puglisi LB; Haque LYK; Lim JK; Justice AC; McGinnis KA
    Am J Public Health; 2023 Feb; 113(2):162-165. PubMed ID: 36480765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategy Configurations Directly Linked to Higher Hepatitis C Virus Treatment Starts: An Applied Use of Configurational Comparative Methods.
    Yakovchenko V; Miech EJ; Chinman MJ; Chartier M; Gonzalez R; Kirchner JE; Morgan TR; Park A; Powell BJ; Proctor EK; Ross D; Waltz TJ; Rogal SS
    Med Care; 2020 May; 58(5):e31-e38. PubMed ID: 32187105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Veterans Affairs Hepatitis C Treatment Considerations.
    Yee HS; Burton MJ; Belperio PS; Morgan TR
    Am J Gastroenterol; 2019 Feb; 114(2):185-188. PubMed ID: 30315291
    [No Abstract]   [Full Text] [Related]  

  • 11. Longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis C treatment: Year 2.
    Rogal SS; Yakovchenko V; Waltz TJ; Powell BJ; Gonzalez R; Park A; Chartier M; Ross D; Morgan TR; Kirchner JE; Proctor EK; Chinman MJ
    Implement Sci; 2019 Apr; 14(1):36. PubMed ID: 30961615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virus.
    Backus LI; Boothroyd DB; Phillips BR; Mole LA
    J Viral Hepat; 2006 Dec; 13(12):799-810. PubMed ID: 17109679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C Treatment at a Veterans Affairs Medical Center After the Availability of Direct-Acting Agents: Things Are Looking Up.
    Lagasca AM; Kan VL
    Clin Infect Dis; 2015 Oct; 61(8):1347-9. PubMed ID: 26187023
    [No Abstract]   [Full Text] [Related]  

  • 14. Resolute efforts to cure hepatitis C: Understanding patients' reasons for completing antiviral treatment.
    Clark JA; Gifford AL
    Health (London); 2015 Sep; 19(5):473-89. PubMed ID: 25377666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care System.
    Yeh WS; Armstrong EP; Skrepnek GH; Malone DC
    Pharmacotherapy; 2007 Jun; 27(6):813-24. PubMed ID: 17542764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
    Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of response of U.S. veterans to treatment for the hepatitis C virus.
    Riley TR
    Hepatology; 2008 Jan; 47(1):356; author reply 356-7. PubMed ID: 18161713
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of hepatitis C disease among VA patients with schizophrenia and substance use disorders.
    Huckans MS; Blackwell AD; Harms TA; Hauser P
    Psychiatr Serv; 2006 Mar; 57(3):403-6. PubMed ID: 16525001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited success of HCV antiviral therapy in United States veterans.
    Cawthorne CH; Rudat KR; Burton MS; Brown KE; Luxon BA; Janney CG; Fimmel CJ
    Am J Gastroenterol; 2002 Jan; 97(1):149-55. PubMed ID: 11808940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate and predictors of treatment prescription for hepatitis C.
    Butt AA; Justice AC; Skanderson M; Rigsby MO; Good CB; Kwoh CK
    Gut; 2007 Mar; 56(3):385-9. PubMed ID: 17005764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.